Moreover, much of the strong Aβ42 labelling outside of plaques in AD transgenic brain occurred in vesicle-like structures of dystrophic neurites that also contained clavesin-1 and 2 and Tsg101, consistent with accumulation of Aβ42 within endosomal compartments of neurons. This evidence concerns the gene CLVS1 and Alzheimer disease.